Triumeq Interactions
There are 214 drugs known to interact with Triumeq (abacavir/dolutegravir/lamivudine), along with 8 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 82 are major, 42 are moderate, and 90 are minor.
- View all 214 medications that may interact with Triumeq
- View Triumeq alcohol/food interactions (6)
- View Triumeq disease interactions (8)
Most frequently checked interactions
View interaction reports for Triumeq (abacavir / dolutegravir / lamivudine) and the medicines listed below.
- acyclovir
- alprazolam
- amlodipine
- aspirin
- atorvastatin
- bupropion
- clonazepam
- doxycycline
- fenofibrate
- gabapentin
- hydrochlorothiazide
- hydroxyzine
- ibuprofen
- levothyroxine
- Lexapro (escitalopram)
- lisinopril
- losartan
- metformin
- omeprazole
- ondansetron
- pantoprazole
- pravastatin
- quetiapine
- rosuvastatin
- tamsulosin
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- zolpidem
Triumeq alcohol/food interactions
There are 6 alcohol/food interactions with Triumeq (abacavir / dolutegravir / lamivudine).
Triumeq disease interactions
There are 8 disease interactions with Triumeq (abacavir / dolutegravir / lamivudine) which include:
- hepatitis B
- hepatotoxicity
- pancreatitis
- cardiovascular disease
- hemodialysis
- hepatitis
- liver impairment
- renal dysfunction
Report options
More about Triumeq (abacavir / dolutegravir / lamivudine)
- Triumeq consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (127)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
